N-(1H-Pyrazolo[3,4-b]pyridin-3-yl)cyclopentanecarboxamide
95%
- Product Code: 50239
CAS:
1789536-63-5
| Molecular Weight: | 230.30 g./mol | Molecular Formula: | C₁₂H₁₄N₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, store under inert gas |
Product Description:
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or building block in the synthesis of various biologically active compounds. Researchers focus on its potential to develop novel therapeutic agents, particularly in the treatment of diseases related to kinase inhibition, such as cancer and inflammatory disorders. Its structure is often modified to enhance drug-like properties, including bioavailability and target specificity. Additionally, it is explored in the development of small-molecule inhibitors that can modulate specific signaling pathways involved in disease progression. Its application extends to high-throughput screening assays to identify potential drug candidates with promising efficacy and safety profiles.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $349.47 |
+
-
|
| 0.250 | 10-20 days | $699.31 |
+
-
|
N-(1H-Pyrazolo[3,4-b]pyridin-3-yl)cyclopentanecarboxamide
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or building block in the synthesis of various biologically active compounds. Researchers focus on its potential to develop novel therapeutic agents, particularly in the treatment of diseases related to kinase inhibition, such as cancer and inflammatory disorders. Its structure is often modified to enhance drug-like properties, including bioavailability and target specificity. Additionally, it is explored in the development of small-molecule inhibitors that can modulate specific signaling pathways involved in disease progression. Its application extends to high-throughput screening assays to identify potential drug candidates with promising efficacy and safety profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :